Precision Medicine For Chronic Diseases

Addressing unmet medical needs

Chronic diseases cause suffering for billions of people and cost trillions of dollars to treat every year.

The challenge for biopharma and healthcare is to understand which targets and drugs will work with which subgroups of patients.

We're a pioneering techbio company, generating the deepest insights into chronic disease biology to unlock patient-focused precision drug discovery, clinical development, and healthcare.

>80%

of healthcare spending is on chronic diseases

90%

of drug programs failed in the last decade

57%

of phase III trial failures due to lack of efficacy

Understanding disease biology better

The one-size-fits-all ‘blockbuster’ approach to medicine is inefficient for everyone.

Biopharma needs better targets that will be successful in clinical trials and healthcare needs better tools and treatments to provide patients with an accurate diagnosis and precision medicines that work for them.

We identify, target, and help treat the biological mechanisms that are driving disease within subgroups of patients, generating stratification biomarkers to improve and derisk pharmaceutical innovation and enable personalized healthcare.

Stratifying patient populations at an unprecedented resolution

Our unique approach finds more signal in patient data than any other method. Our high-resolution patient stratification identifies subgroups of patients with similar disease drivers and treatment responses, to make precision medicine possible in chronic diseases.

Our insights discover new drug targets, accelerate successful clinical development, find drug repositioning opportunities, and lead to better diagnosis and the prescription of more effective therapies.

Driving precision medicine

We've created an AI-led Innovation Engine, powered by our unique combinatorial analytics, to stratify patient populations at the highest resolution, finding all the factors associated with disease for subgroups of patients.

Partner with us to:

✔ Discover novel drug targets and leads for unmet medical needs
✔ Identify drug repositioning candidates for patient subgroups
✔ Accelerate and derisk clinical development
✔ Predict and prevent chronic disease in patients early
✔ Design more accurate diagnostic and clinical decision support tools